Impact Biomedical INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
SCHEDULE 13D/A: Key Insiders Drastically Reduce Stake in IMPACT BIOMEDICAL INC., Selling Millions of Shares
Heng Fai Ambrose Chan and his affiliated entities, Alset Inc., Alset International Limited, and Global Biomedical Pte. Ltd., have significantly reduced their beneficial ownership in IMPACT BIOMEDICAL INC. through a series of share sales in late March and early April 2025.
AMEX
A group of affiliated entities led by Heng Fai Ambrose Chan has significantly reduced its beneficial ownership in IMPACT BIOMEDICAL INC. through recent share sales.